您要查找的是不是：
- Mycophenolate mofetil capsule 吗替麦考酚酯胶囊
- mycophenolate mofetil capsules 吗替麦考酚酯胶囊
- GVHD prophylaxis regimen consisted of cyclosporine(CsA) and mycophenolate mofetil (MMF). 移植物抗宿主病 (GVHD)的预防采用环孢菌素A(csa) +霉酚酸酯 (MMF)方案。
- Other studies hae added cyclophosphamide and/or mycophenolate mofetil to the plasmapheresis protocol. 另外一些研究将环磷酰胺和/或霉酚酸酯与血浆置换联合应用。
- The drugs with large consumption of anti-rejection drugs were cyclosporin,tacrolimus and mycophenolate mofetil. 环孢素、霉酚酸酯和他克莫司的消耗较大；
- Mycophenolate mofetil (MMF) was started 3 weeks before the third transplantation, and preoperative plasmapheresis performed thrice. 第三次移植前3周即开始使用MMF，并在移植前行三次血浆置换。
- BACKGROUND: The outcomes of preious trials of mycophenolate mofetil (MMF) in treating seere lupus nephritis (LN) are not in exact agreement. 研究背景：以往关于霉酚酸酯治疗重症狼疮性肾炎的研究结果并不一致。
- Other studies hae added cyclophosphamide and/or mycophenolate mofetil to the plasmapheresis protocol.Again success in these studies has been ariable. 其他的研究者在血浆置换疗法上加用了环磷酰胺或/和霉酚酸酯，同样获得了变异的成功。
- The immunosuppressive regimen consisted of tacrolimus, prednisolone, mycophenolate mofetil (or cyclophosphamide), and prostaglandin E1 in all patients. 免疫抑制方案包括他克莫司、强的松、霉酚酸酯（或环磷酰胺）和前列腺素E1。
- Sollinger HW. Update of preclinical and clinical experience with mycophenolate mofetil[J]. Transplant-proc 1996; 12; 28(6 suppl 1): 24-9. 胡伟新，黎磊石.;重症狼疮性肾炎合并感染和肾衰霉酚酸酯[J]
- Objective: To investigate the efficacy and safety of mycophenolate mofetil( MMF) in the treatment of membranous nephropathy with primary nephrotic syndrome. 目的:研究霉酚酸酯(mf)疗膜性肾病型原发性肾病综合征的疗效和安全性。
- To compare the effects of treatment methods between Mycophenolate mofetil(MMF)and azathioprine(AZT)combined with prednisone respectively in treating HBV_GN. 目的 :对比霉酚酸酯 (MMF)联合强的松与硫唑嘌呤联合强的松治疗乙肝病毒相关性肾炎 (HBV_GN)的疗效。
- Burra, steroid-sparing is feasible with tacrolimus or cyclosporine A based protocols with mycophenolate mofetil (MMF) and 1 intraoperative dose of steroid. 可以以他克莫司或环孢菌素A为基础，联合麦考酚酸莫酯，并在术中给予1次类固醇治疗。
- Therefore, newer immunosuppressie agents such as mycophenolate mofetil and sirolimus (Rapa) hae raised the possibility of withdrawing or aoiding CNIs altogether. 因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使CNI撤退或避免其使用的可行性上升。
- BACKGROUND: Animal and limited human studies hae raised concerns as to the safety of in utero exposure to mycophenolate mofetil (MMF) and sirolimus (SRL) in transplant recipients. 背景：通过动物实验及有限的人体研究，移植受者宫内妊娠时骁悉(MMF)或西罗莫司(SRL)暴露的安全性越来越受到关注。
- Therefore, newer immunosuppressive agents such as mycophenolate mofetil and sirolimus (Rapa) have raised the possibility of withdrawing or avoiding CNIs altogether. 因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使CNI撤退或避免其使用的可行性上升。
- Hu W, Liu Z, Chen H, et a1. Mycophenolate mofetil vs cyclophosphamide therapy of patients with diffuse proliferative lupus nephritis[J]. Chin Med J(Eng), 2002,115(5):705-709. 吗替麦考酚酯联合泼尼松治疗难治性狼疮性肾炎的疗效观察由800论文网收集整理，转载请注明出处！
- In this paper,some new immun osupressants,such as mycophenolate mofetil,tacrolimus,sirolimus,daclizumab and b asiliximab,were reviewed in conjunction with drug concentration monitoring. 结合治疗药物浓度监测，本文就免疫抑制药物的研究进展作一综述。
- In this paper,some new immunosupressants,such as mycophenolate mofetil,tacrolimus,sirolimus,daclizumab and basiliximab,were reviewed in conjunction with drug concentration monitoring. 结合治疗药物浓度监测,本文就免疫抑制药物的研究进展作一综述。
- Objective To observe the clinical curative effect of mycophenolate mofetil combined with entecavir in the treatment of patients with hepatitis B virus associated nephritis(HBV-GN). 目的观察吗替麦考酚酯联合恩替卡韦治疗乙型肝炎病毒相关性肾炎的疗效。
